UFP Technologies reported a strong Q3 2024 with a 44% increase in sales to $145.2 million and a 40% increase in net income to $16.4 million, driven by organic growth and the performance of recent acquisitions. Gross margins also increased to 28.6%.
Net income increased 40% to $16.4 million compared to Q3 2023.
Sales increased 44% to $145.2 million compared to Q3 2023.
Organic sales grew 9.7%, driven by robotic surgery and infection prevention markets.
Recent acquisitions were accretive to EPS by approximately $0.17 after absorbing increased interest expenses.
UFP Technologies remains optimistic about its future, focusing on growth initiatives, integration of acquisitions, and strengthening its platform to enhance customer value and achieve future success.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance